Replies to post #674 on Enanta Pharmaceuticals Inc (ENTA)

[linhdtu]

Willy, it's OK , there is no need to keep beating a dead horse aka AF lol.
A few days ago I asked Dew about Rgls results and he answered me. I don't have search privileges but to sum it up, rgls still has a long way to go til approval and the results were not that stellar by today's standards.
Just try to keep your own books on who said what,where and why.
In fact that is a very good advice from many finance books I read over the yrs.
In the same vein, keep track of your own buying and selling. Why you bought and why you sold.
Matter of fact, for yrs because I was lazy in keeping a log of my own trading, whenever I sold out for whatever reason (most because I think it is fully valued etc...) I don't sell all.
Say I have 10Ksh of enta, when I bail , I keep 100sh. That way whenever I check my portfolio it reminded whether my reason(s)for selling was right or wrong.

[DewDiligence]

…some were able to attain a SVR without [a DAA], so I would assume that given a decent antiviral (or two) there is potential there.

To be clear: RGLS did not produce any SVRs (viral-free patients 12 weeks after the end of treatment), but rather 6 of 14 RVRs (viral-free patients 12 weeks after the start of treatment). Big difference!